LETTER
Synthesis of the Erythrina and B-Homoerythrina Alkaloid Skeleton
527
(5) (a) Stanislawski, P. C.; Willis, A. C.; Banwell, M. G. Org.
Lett. 2006, 8, 2143. (b) Padwa, A.; Wang, Q. J. Org. Chem.
2006, 71, 7391. (c) Ganguly, A. K.; Wang, C. H.; Biswas,
D.; Misiaszek, J.; Micula, A. Tetrahedron Lett. 2006, 47,
5539. (d) Gao, S.; Tu, Y. Q.; Hu, X.; Wang, S.; Hua, R.;
Jiang, Y.; Zhao, Y.; Fan, X.; Zhang, S. Org. Lett. 2006, 8,
2373. (e) Fukumoto, H.; Takahashi, K.; Ishihara, J.;
Hatakeyama, S. Angew. Chem. Int. Ed. 2006, 45, 2731.
(6) General Procedure
lar electrophilic attack at the aromatic ring to give the spi-
rocyclic product 4a.
The described process is much more convenient than the
reaction of the enol acetate of the keto esters 3a or 3b7
since it saves one step and gives better yields. We have in-
vestigated the use of other acids for the C-ring closure;
however, TfOH was the only reagent which allowed the
cyclization. It should be pointed out that the aryl ethyl
amines 2a and 2b with 3a gave similar results, though the
electron density of the aromatic moiety of the two sub-
strates, being important for the electrophilic aromatic sub-
stitution, is different. Thus, in the case of the
methylenedioxy-substituted compound the electron den-
sity should be lower due to a reduced overlap of the non-
bonding electron pairs at the oxygen atoms of the 1,3-
dioxy moiety and the π-system of the aromatic ring due to
an anomeric effect. However, acyl iminium ions as 10 are
highly reactive species that this difference of electron den-
sity does not affect the transformation in this case.
To a stirred solution of amine 2 (1.00 equiv) in MeCN (0.5
mL/mmol) was added dropwise at 0 °C AlMe3 (2.00 M in
toluene, 2.00 equiv), then In(OTf)3 (4–25 mol%) and the
ester 3 (1.00 equiv), and stirring was continued for 3–17 h at
r.t. or the mixture was heated to 100–180 °C under
microwave irradiation. The reaction mixture was cooled to
0 °C, TfOH (3.5 equiv) was added dropwise and stirring was
continued for 5 h at r.t. Subsequently, the mixture was
quenched by addition of sat. aq NaHCO3 at 0 °C with stirring
for 20 min. The mixture was extracted with EtOAc, the
combined organic layers were washed with brine, dried over
Na2SO4, and the solvent was removed under reduced
pressure. The crude product was subjected to column
chromatography to yield 38–99% of the spirocycle 4.
Compound 4a: 1H NMR (300 MHz, DMSO): δ = 1.35–1.60
(m, 5 H, 3-H2, 2-H2, 1-Ha), 1.75–1.82 (m, 2 H, 4-H2), 1.95–
1.99 (m, 1 H, 1-Hb), 2.12 (mc, 2 H, 7-H2), 2.54–2.60 (m, 1 H,
6-H), 2.63 (ddd, J = 3.0, 6.0, 16.5 Hz, 1 H, 11-Ha), 2.80 (ddd,
J = 7.4, 10.0, 16.5 Hz, 1 H, 11-Hb), 3.15 (ddd, J = 6.0, 10.0,
13.2 Hz, 1 H, 10-Ha), 3.71 (s, 3 H, OCH3), 3.76 (s, 3 H,
OCH3), 3.86 (ddd, J = 3.0, 7.4, 13.2 Hz, 1 H, 10-Hb), 6.67 (s,
1 H, 17-H), 6.91 (s, 1 H, 14-H). 13C NMR (300 MHz,
DMSO): δ = 20.06 (C-2), 20.57 (C-3), 26.14 (C-11), 27.17
(C-1), 34.26 (C-10), 35.01 (C-4), 36.29 (C-7), 36.67 (C-6),
55.42 (OCH3), 55.74 (OCH3), 61.75 (C-5), 108.7 (C-14),
112.5 (C-17), 125.5 (C-12), 134.7 (C-13), 147.0 (C-16),
147.5 (C-15), 173.6 (C-8).
The presented domino reaction with the formation of three
bonds is a highly efficient process, which allows the syn-
thesis of the erythrina and B-homoerythrina alkaloid skel-
etons in up to 99% yield.
Acknowledgment
This work has been supported by the DFG and the Fonds of the Ger-
man Chemical Industry.
References and Notes
Compound 4b: 1H NMR (300 MHz, DMSO): δ = 1.18–1.42
(m, 2 H, 11-Ha, 13*-Ha), 1.42–1.69 (m, 5 H, 2-H2, 12*-H2,
13*-Hb), 1.69–1.82 (m, 2 H, 1-H2), 2.05 (dd, J = 18.5, 6.2
Hz, 1 H, 14-Ha), 2.18–2.26 (m, 1 H, 11-Hb), 2.33–2.47 (m, 1
H, 14-Hb), 2.52 (d, J = 5.9 Hz, 1 H, 6-Ha), 2.63 (mc, 1 H, 14a-
H), 2.84–2.99 (m, 1 H, 6-Hb), 3.19 (td, J = 12.3, 5.9 Hz, 1 H,
5-Ha), 3.70 (s, 3 H, OCH3), 3.73 (s, 3 H, OCH3), 4.53 (dd,
J = 13.2, 7.5 Hz, 1 H, 5-Hb), 6.62 (s, 1 H, 7-H), 6.82 (s, 1 H,
10-H). 13C NMR (300 MHz, DMSO): δ = 21.42 (C-13*),
22.15 (C-12*), 25.07 (C-1), 25.60 (C-2), 26.06 (C-6), 28.14
(C-14), 34.48 (C-5), 34.77 (C-14a), 39.58 (C-11), 55.32
(OCH3), 55.89 (OCH3), 60.99 (C-10b), 107.2 (C-10), 112.9
(C-7), 126.5 (C-6a), 135.8 (C-10a), 146.9 (C-9), 147.4 (C-8),
171.0 (C-3).
(1) (a) Tietze, L. F.; Brasche, G.; Gericke, K. M. Domino
Reactions in Organic Synthesis; Wiley-VCH: Weinheim,
2006. (b) Tietze, L. F.; Haunert, F. In Stimulating Concepts
in Chemistry; Shibasaki, M.; Stoddart, J. F.; Vögtle, F., Eds.;
Wiley-VCH: Weinheim, 2000, 39. (c) Tietze, L. F.; Modi,
A. Med. Res. Rev. 2000, 20, 304. (d) Tietze, L. F. Chem.
Rev. 1996, 115. (e) Tietze, L. F.; Beifuss, U. Angew. Chem.,
Int Ed. Engl. 1993, 32, 131.
(2) Krukoff, B. A.; Barneby, R. C. Mem. New York Bot. Gard.
1970, 20, 1.
(3) (a) Chawla, A. S.; Kapor, V. K. In Handbook of Plant and
Fungal Toxicants; D’Mello, J. F., Ed.; CRC Press: New
York, 1997, 37. (b) Bhakuni, D. S. J. Indian Chem. Soc.
2002, 203. (c) Lehman, A. J. J. Pharmacol. 1937, 69.
(d) Williams, M.; Robinson, J. L. J. Neurosci. 1984, 2906.
(e) Decker, M. W.; Anderson, D. J.; Brioni, J. D.; Donnelly-
Roberts, D. L.; Kang, C. H.; O’Neil, A. B.; Piattoni-Kaplan,
M.; Swanson, S.; Sullivan, J. P. Eur. J. Pharmacol. 1995, 79.
(4) (a) Boekelheide, V. In The Alkaloids, Vol. 7; Manske, R. H.
F., Ed.; Academic Press: New York, 1960, 201. (b) Hill, R.
K. In The Alkaloids, Vol. 9; Manske, R. H. F., Ed.;
Academic Press: New York, 1967, 483. (c) Dyke, S. F.;
Quessy, S. N. In The Alkaloids, Vol. 18; Rodrigo, R. G. A.,
Ed.; Academic Press: New York, 1981, 1. (d) Jackson, A.
H. In Chemistry and Biology of Isoquinoline Alkaloids;
Phillipson, J. D.; Margaret, M. F.; Zenk, M. H., Eds.;
Springer: Berlin, 1985, 62. (e) Chawla, A. S.; Jackson, A. H.
Nat. Prod. Rep. 1984, 1, 371.
Compound 4c: 1H NMR (300 MHz, DMSO): δ = 1.28–1.48
(m, 3 H, 3-H2, 1-Ha), 1.49–1.58 (m, 2 H, 2-H2), 1.71–1.75
(m, 1 H, 4-Ha), 1.78–1.83 (m, 1 H, 4-Hb), 1.91–1.99, (m, 1
H, 1-Hb), 2.09–2.14 (m, 2 H, 7-H2), 2.49–2.54 (m, 1 H, 6-
H), 2.59–2.67 (m, 1 H, 11-Ha), 2.73–2.87 (m, 1 H, 11-Hb),
3.11–3.21 (m, 1 H, 10-Ha), 3.78–3.85 (m, 1 H, 10-Hb), 5.94
(s, 2 H, 18-H2), 6.65 (s, 1 H, 17-H), 6.97 (s, 1 H, 14-H). 13
C
NMR (300 MHz, DMSO): δ = 19.90 (C-2), 20.49 (C-3),
26.58 (C-11), 27.02 (C-1), 34.25 (C-10), 35.01 (C-4), 36.22
(C-7), 36.71 (C-6), 62.13 (C-5), 100.7 (C-18), 104.9 (C-14),
108.7 (C-17), 126.8 (C-12), 135.9 (C-13), 145.6 (C-
16), 145.7 (C-15), 173.6 (C-8).
Compound 4d: 1H NMR (300 MHz, DMSO): δ = 1.20–1.35
(m, 2 H, 11-Ha, 13*-Ha), 1.35–1.52 (m, 2 H, 1-H2), 1.50–1.80
(m, 5 H, 2-H2, 12*-H2, 13*-Hb), 2.04 (dd, J = 18.6, 6.6 Hz, 1
H, 14-Ha), 2.18–2.25 (m, 1 H, 11-Hb), 2.32–2.44 (m, 1 H, 14-
Hb), 2.55–2.70 (m, 2 H, 6-Ha, 14a-H), 2.80–2.92 (m, 1 H, 6-
Synlett 2008, No. 4, 525–528 © Thieme Stuttgart · New York